National Stock Number
6505-01-362-7427
National Stock Number (NSN) 6505-01-362-7427, or NIIN 013627427, (antidote treatment - nerve agent) was assigned August 14, 1992 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.
There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Jun 24, 2015. There have been 2 contracts issued for this part number, with 15 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPM2DP11D0002, SPM2DP11D0002, SPM2DP11D0002, SPM2DP11D0002, SPM2DP11D0002. The total value of the awarded contracts has been US$ 95,404,322.39.
This NSN is somewhat common among different platforms, belonging to 4 different weapons systems.
There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Jan 21, 2012, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) The Government physically does not have in its possession sufficient, accurate, or legible data to purchase this part from other than current source(s). (NOTE: This code is applicable only to parts under immediate buy requirements and only as long as the deficiency is under review for resolution and appropriate recoding.) Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 77777. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Information is in the Hazardous Materials Information Resource System (HMIRS). NSN 6505013627427 does not contain precious metals.
This NSN is associated to Schedule B 3004400040: other medicaments primarily affecting the central nervous system not elsewhere specified or included. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on May 01, 2025.